Most Recent
A Melbourne cafe embroiled in a Fair Work battle over alleged staff underpayments has now been hit with a $185,000 fine for copyright infringement in a separate case brought against it by the Phonographic Performance Company of Australia.
A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.
Take-Two interactive has won an injunction blocking a Grand Theft Auto gamer from distributing software that allows users to access restricted features of the popular game, a month after reaching a settlement with a gamer in a separate copyright case.
Preparations for a December trial between Merck Sharp & Dohme Corporation and Wyeth over four patents for the pneumococcal disease vaccine are underway, and a panel of experts will feature prominently in the high-stakes hearing over the world's best-selling vaccine.
A Melbourne computer retailer that plans to appeal a $2.8 million fine for allegedly violating Microsoft's Windows 7 IP has won a stay of the court's order, with a judge finding the court's delay in publishing reasons for judgment created an "unsatisfactory state of affairs".
An IVF clinic that pioneered the use of artificial intelligence for embryo selection has sued a rival clinic for allegedly copying an advertising campaign featuring the slogan "more chubby cheeks".
A popular Australian designer of neoprene athleisure handbags has filed a lawsuit against another designer for making bags that allegedly copy the design of its trendy totes.
The Department of Agriculture and Water Resources has proposed a wine label directory meant to safeguard the intellectual property of Australian wine makers by making it easier to detect and bring lawsuits against copycats.
A Melbourne retailer is challenging a $2.8 million fine against it for allegedly violating the intellectual property for Microsoft's Windows 7 software.
A patent for genome editing technology by a South Korean biotechnology company has been rejected for a lack of clarity, novelty, and inventiveness, but the Australian Patent Office has given the company two months to try again.